Company · CIK 0001028205
BIOENVISION INC
Exchange
—
Entity type
operating
Fiscal year end
Jun 30
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13D/ABIOENVISION INC0000950136-07-006779 · 143.8 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-07-063037 · 36.8 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-07-057030 · 16.5 KBSEC(opens sec.gov)
- 4Insider trades0000950142-07-001594 · 24.8 KBSEC(opens sec.gov)
- SC 13D/ABIOENVISION INC0000950142-07-001590 · 46.6 KBSEC(opens sec.gov)
- 4Insider trades0001116679-07-001828 · 5.3 KBSEC(opens sec.gov)
- 4Insider trades0001116679-07-001826 · 5.3 KBSEC(opens sec.gov)
- 4Insider trades0001116679-07-001824 · 5.3 KBSEC(opens sec.gov)
- 4Insider trades0001116679-07-001822 · 5.3 KBSEC(opens sec.gov)
- SC 13D/ABIOENVISION INC0000950136-07-004627 · 98.0 KBSEC(opens sec.gov)
Insiders
- Abercrombie IanSales Director, Europe
- GENZYME CORP10% Owner
- LUCI DAVID PEVP & General Counsel
- Nelson Thomas ScottDirector
- PERSEUSPUR LLC10% Owner
- PERSEUS SOROS BIOPHARMACEUTICAL FUND LP10% Owner
- PERSEUS SOROS PARTNERS LLC10% Owner
- Rouhandeh Steven H10% Owner
- SCO CAPITAL PARTNERS LLC10% Owner
- SFM PARTICIPATION LP10% Owner
Tickers
No tickers on record.
Addresses
business
345 PARK AVENUE 41ST FLOOR
NEW YORK, NY, 10154
mailing
345 PARK AVENUE 41ST FLOOR
NEW YORK, NY, 10154
Former names
- ASCOT GROUP INC1999-01-12
Same industry